UBS Leadership and Capital Rules on Collision Course

UBS shareholders approved all proposals, but the bank's future hinges on a capital rule fight with Swiss regulators and a delayed CEO succession plan.

The annual meeting in Basel was a smooth affair for UBS shareholders, who approved all board proposals without a hitch. Yet beneath the formal unanimity, two unresolved and deeply intertwined issues now dictate the bank’s immediate future: an escalating confrontation with Swiss regulators and a prolonged search for a new chief executive.

Chairman Colm Kelleher delivered an unambiguous ultimatum to the Swiss government. He stated that UBS will examine its options unless proposed capital rules are significantly softened. The Federal Council's current draft would force the bank to hold up to $26 billion in additional core capital. Kelleher labeled the requirements "extreme," arguing they offer little added benefit for financial stability. A specific clause concerning the treatment of intangible assets alone would demand about $3 billion in fresh capital for the Swiss unit.

A CEO Stays Put Amid the Fray

The regulatory standoff has directly frozen plans for leadership succession. According to Reuters reports, CEO Sergio Ermotti is now expected to remain in his post well into the second half of 2027. The board views him as indispensable for navigating the capital negotiations, which may drag on until 2028. With the complex integration of Credit Suisse ongoing and slated for completion by late 2026 or early 2027, the bank is unwilling to risk a leadership change during this period of heightened uncertainty.

Shareholders did endorse a reshaped board, injecting new expertise. Luca Maestri, the long-serving CFO of Apple, and Agustín Carstens, former General Manager of the Bank for International Settlements and ex-governor of Mexico's central bank, were newly elected. William C. Dudley and Jeanette Wong did not stand for re-election. Notably, Chairman Kelleher received 88% approval, the lowest of all candidates—a notable, if still comfortable, figure for a routine vote.

Financial Metrics and Shareholder Returns in the Balance

The meeting yielded concrete rewards for investors, including a 22% dividend increase to $1.10 per share. This follows a net annual profit of $7.8 billion. However, Kelleher explicitly ruled out shrinking the bank as a response to tighter rules, while making future share buybacks directly contingent on the regulatory outcome. For shareholders, this link is critical: less buyback capacity means reduced capital returns.

The bank's performance benchmarks remain ambitious. UBS recently reported its first year with over $7 trillion in managed assets and raised its synergy target from the Credit Suisse integration to $13.5 billion. For 2026, management is targeting a return on equity of approximately 15% as a year-end exit rate.

A Pivotal April for Clarity

Two key dates now set the rhythm. On April 22, the Federal Council will decide on the draft capital legislation, sending a signal to parliament before it debates the overarching law on capitalizing foreign units in early May. Just one week later, on April 29, UBS will release its first-quarter 2026 results. This report will offer the first concrete evidence of whether operational profitability and the integration can support the targeted ROE, or if regulatory pressure is already leaving a mark.

The stock, trading around EUR 36.60, sits comfortably above its 200-day moving average of EUR 34.87. Yet it remains nearly 11% below its January peak of EUR 41.10 and is down roughly 9% year-to-date. The coming weeks will determine if political and financial pressures converge to push it lower, or if a regulatory compromise can clear a path for the bank's strategic goals.